🇺🇸 FDA
Patent

US 11958893

Methods for modulating an immune response

granted A61KA61K2039/505A61K38/1774

Quick answer

US patent 11958893 (Methods for modulating an immune response) held by Cue Biopharma, Inc. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cue Biopharma, Inc.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K38/1774, A61K38/2013, A61K39/3955